Mehdi Azad

1.0k total citations
67 papers, 775 citations indexed

About

Mehdi Azad is a scholar working on Molecular Biology, Hematology and Infectious Diseases. According to data from OpenAlex, Mehdi Azad has authored 67 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 14 papers in Hematology and 10 papers in Infectious Diseases. Recurrent topics in Mehdi Azad's work include Epigenetics and DNA Methylation (13 papers), Cancer-related gene regulation (7 papers) and Acute Lymphoblastic Leukemia research (6 papers). Mehdi Azad is often cited by papers focused on Epigenetics and DNA Methylation (13 papers), Cancer-related gene regulation (7 papers) and Acute Lymphoblastic Leukemia research (6 papers). Mehdi Azad collaborates with scholars based in Iran, Malaysia and Russia. Mehdi Azad's co-authors include Mehdi Goudarzi, Sima Sadat Seyedjavadi, Naser Mobarra, Mehdi Sahmani, Hajar Nasiri, Hassan Ehteram, Mehrnoosh Shanaki, Mohsen Saeidi, Maryam Fazeli and Amirhosein Maali and has published in prestigious journals such as SHILAP Revista de lepidopterología, Critical Reviews in Oncology/Hematology and Journal of Human Nutrition and Dietetics.

In The Last Decade

Mehdi Azad

59 papers receiving 758 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mehdi Azad Iran 16 339 166 104 100 92 67 775
Yun Su United States 13 223 0.7× 74 0.4× 92 0.9× 55 0.6× 89 1.0× 33 748
Satomi Asai Japan 17 190 0.6× 89 0.5× 79 0.8× 32 0.3× 98 1.1× 78 723
Yoshiaki Abe Japan 15 318 0.9× 138 0.8× 86 0.8× 142 1.4× 202 2.2× 74 1.1k
Chong Wang China 20 412 1.2× 97 0.6× 88 0.8× 59 0.6× 110 1.2× 71 1.0k
Yutaka Saikawa Japan 19 480 1.4× 227 1.4× 54 0.5× 42 0.4× 235 2.6× 57 1.2k
Ana Cordeiro Gomes Portugal 12 187 0.6× 337 2.0× 35 0.3× 180 1.8× 163 1.8× 19 851
Kacper A. Wojtal Switzerland 15 427 1.3× 69 0.4× 34 0.3× 42 0.4× 165 1.8× 20 1.0k
Hassan Ehteram Iran 11 115 0.3× 103 0.6× 71 0.7× 85 0.8× 37 0.4× 32 486
Timothy L. Zisman United States 13 482 1.4× 80 0.5× 236 2.3× 119 1.2× 108 1.2× 21 1.2k
Potukuchi Venkata Gurunadha Krishna Sarma India 15 313 0.9× 66 0.4× 133 1.3× 57 0.6× 96 1.0× 70 695

Countries citing papers authored by Mehdi Azad

Since Specialization
Citations

This map shows the geographic impact of Mehdi Azad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehdi Azad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehdi Azad more than expected).

Fields of papers citing papers by Mehdi Azad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mehdi Azad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehdi Azad. The network helps show where Mehdi Azad may publish in the future.

Co-authorship network of co-authors of Mehdi Azad

This figure shows the co-authorship network connecting the top 25 collaborators of Mehdi Azad. A scholar is included among the top collaborators of Mehdi Azad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mehdi Azad. Mehdi Azad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maali, Amirhosein, et al.. (2024). Epigenetic-modifying agents: The potential game changers in the treatment of hematologic malignancies. Critical Reviews in Oncology/Hematology. 204. 104498–104498. 1 indexed citations
2.
Maali, Amirhosein, et al.. (2023). Natural Killer Cell Epigenetic Reprogramming in Tumors and Potential for Cancer Immunotherapy. Epigenomics. 15(4). 249–266. 4 indexed citations
3.
Maali, Amirhosein, et al.. (2022). Therapeutic approaches and vaccination in fighting COVID-19 infections: A review. Gene Reports. 27. 101619–101619. 6 indexed citations
4.
Maali, Amirhosein, et al.. (2020). CRISPR-Mediated Modification of DNA Methylation Pattern in the New Era of cancer therapy. Epigenomics. 12(20). 1845–1859. 20 indexed citations
5.
Atashi, Amir, et al.. (2019). Upregulation of Pro-inflammatory Cytokine Genes by Parvovirus B19 in Human Bone Marrow Mesenchymal Stem Cells. Biochemical Genetics. 58(1). 63–73. 4 indexed citations
6.
Maali, Amirhosein, et al.. (2019). Updates on Novel Erythropoiesis-Stimulating Agents: Clinical and Molecular Approach. Indian Journal of Hematology and Blood Transfusion. 36(1). 26–36. 6 indexed citations
7.
Kaviani, Saeid, et al.. (2018). Various Signaling Pathways in Multiple Myeloma Cells and Effects of Treatment on These Pathways. Clinical Lymphoma Myeloma & Leukemia. 18(5). 311–320. 38 indexed citations
8.
Goudarzi, Mehdi, et al.. (2016). Investigation of Leukemia Frequency in Children of Qazvin Province and its Correlation with Gender, Age, and Blood Groups between 2006-2016. SHILAP Revista de lepidopterología. 1 indexed citations
9.
Shanaki, Mehrnoosh, Hassan Ehteram, Hajar Nasiri, et al.. (2016). Assessment of Liver and Kidney Functional Parameters along with oxidative Stress and Inflammatory Biomarker in Patients with β-Thalassemia major. 6(4). 249–260. 1 indexed citations
10.
Azad, Mehdi, et al.. (2015). Correlation between Methylation and Expression Level of P15 and P16 Genes during Differentiation of Cord Blood Stem Cells into Erythroid Lineage Mediated by Erythropoietin. SHILAP Revista de lepidopterología. 2 indexed citations
11.
Goudarzi, Mehdi, Maryam Fazeli, Mehdi Azad, & Sima Sadat Seyedjavadi. (2015). Survey of clinical features, pathogenesis and therapeutic options for Ebola haemorrhagic fever. Journal of paramedical sciences.. 6(3). 145–152. 2 indexed citations
12.
Eskandari, Fatemeh, et al.. (2015). Lentiviral vectors titration using real-time PCR. Journal of paramedical sciences.. 6(1).
13.
Goudarzi, Mehdi, et al.. (2015). Profile of side Effects in Patients Receiving Blood Transfusion from the Perspective of Management Unit. SHILAP Revista de lepidopterología. 3(4). 200–206. 1 indexed citations
14.
Goudarzi, Mehdi, et al.. (2014). Prevalence of blaCTX-M gene in multi-resistant Escherichia coli isolated from Urinary Tract Infections, Tehran, Iran. SHILAP Revista de lepidopterología. 3 indexed citations
15.
Goudarzi, Mehdi, et al.. (2014). Study of flagellin profiling in multidrug resistant Pseudomonas aeruginosa (MDRPA) isolated from burn wound infections, Tehran, Iran. Journal of paramedical sciences.. 5(3). 3 indexed citations
16.
Goudarzi, Mehdi, et al.. (2014). Characterization of coagulase-negative staphylococci isolated from hospitalized patients in Tehran, Iran. Journal of paramedical sciences.. 5(2). 9 indexed citations
17.
Mortazavi, Yousef, et al.. (2014). THE EXPERTS' VIEWS ON CHALLENGES AND NEEDS FOR DIAGNOSIS AND TREATMENT PROCESS OF BLOOD CANCER IN IRAN. Journal of Advances in Medical and Biomedical Research. 22(91). 61–72. 2 indexed citations
18.
Goudarzi, Mehdi, et al.. (2014). Challenges in the treatment of Iranian patients with leukemia in comparison with developed countries from the perspective of specialists. Journal of paramedical sciences.. 5(4). 4 indexed citations
19.
Azad, Mehdi, et al.. (2013). Evaluating the Methylation Status in Promoter of vHL, Runx3 and Ecad Genes and Expression of These Genes in Cord Blood CD34+ Stem Cells. Journal of Advances in Medical and Biomedical Research. 21(86). 12–23.
20.
Azad, Mehdi, et al.. (2009). Frequency of the most prevalent Thiopurine S-Methyl Trasferase alleles in referrals to Shariati Hospital in Tehran. 12(1). 1–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026